Cann Group to target institutional investors after capital raise falls short by Steve Jones July 28, 2023April 30, 2024 Cann Group has raised A$4.46 million from shareholders in its latest capital raise – just over […]
Cann Group aims for profitability ‘within two years’ as revenue doubles in FY23 by Steve Jones July 5, 2023April 30, 2024
Cann Group in multimillion-dollar cap raise to fund Mildura production growth by Steve Jones June 15, 2023April 30, 2024
Revenues and costs on the rise as Cann Group increases Mildura production by Steve Jones April 28, 2023April 30, 2024
Cann Group to focus on ‘production at scale’ as new CEO beds down by Steve Jones February 28, 2023April 30, 2024
We’ve put our money where our mouth is, says Cann Group as focus turns to generating revenue by Steve Jones November 11, 2022April 29, 2024
Cann Group looks to raise another A$10m for Mildura, puts Southern facility up for sale by Martin Lane October 25, 2022April 29, 2024
‘Being a start-up in a start-up industry is not easy. It’s been turbulent. But we’re ready to go.’ by Steve Jones August 29, 2022April 29, 2024
Cann Group secures additional funding from NAB, lights up Mildura night sky by Martin Lane July 21, 2022April 29, 2024
Company news: Cann Group; Medlab; ANTG; Medleaf; Ora Pharm; Creso Pharma; Greenfern Industries by Martin Lane June 30, 2022April 29, 2024
